Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Apr;96(1):1–7. doi: 10.1111/j.1365-2249.1994.tb06220.x

Cytokines and autoimmunity.

M G Cavallo 1, P Pozzilli 1, R Thorpe 1
PMCID: PMC1534543  PMID: 8149655

Abstract

Although the immunopathology of most autoimmune diseases has been well defined, the mechanisms responsible for the breakdown of self-tolerance and which lead to the development of systemic and organ-specific autoaggression are still unclear. Evidence has accumulated which supports a role for a disregulated production of cytokines by leucocytes and possibly other cells in the pathogenesis of some autoimmune diseases. However, due to the complexity and heterogeneity of cytokine effects in the regulation of the immune response, it is difficult to determine whether abnormalities in the patterns of cytokine production are primary or secondary to the pathological process. Confusion is also caused by the fact that the biological activities of cytokines are multiple and often overlapping, and consequently it is difficult to focus on a unique effect of any one cytokine. Characterization of the potential and actual involvement of cytokines is important not only for a better understanding of the pathogenesis of autoimmune conditions, but particularly because of the implications for the development of immunotherapeutic strategies for the prevention and treatment of the diseases.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J., Campbell I. L., Morahan G., Mandel T. E., Harrison L. C., Miller J. F. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature. 1988 Jun 9;333(6173):529–533. doi: 10.1038/333529a0. [DOI] [PubMed] [Google Scholar]
  2. Allison J., Malcolm L., Chosich N., Miller J. F. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells. Eur J Immunol. 1992 May;22(5):1115–1121. doi: 10.1002/eji.1830220503. [DOI] [PubMed] [Google Scholar]
  3. Atkins M. B., Mier J. W., Parkinson D. R., Gould J. A., Berkman E. M., Kaplan M. M. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med. 1988 Jun 16;318(24):1557–1563. doi: 10.1056/NEJM198806163182401. [DOI] [PubMed] [Google Scholar]
  4. Bendtzen K., Buschard K., Diamant M., Horn T., Svenson M. Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group. Lymphokine Res. 1989 Fall;8(3):335–340. [PubMed] [Google Scholar]
  5. Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science. 1986 Jun 20;232(4757):1545–1547. doi: 10.1126/science.3086977. [DOI] [PubMed] [Google Scholar]
  6. Bendtzen K., Svenson M., Jønsson V., Hippe E. Autoantibodies to cytokines--friends or foes? Immunol Today. 1990 May;11(5):167–169. doi: 10.1016/0167-5699(90)90068-k. [DOI] [PubMed] [Google Scholar]
  7. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  8. Bottazzo G. F., Pujol-Borrell R., Hanafusa T., Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 1983 Nov 12;2(8359):1115–1119. doi: 10.1016/s0140-6736(83)90629-3. [DOI] [PubMed] [Google Scholar]
  9. Buchan G., Barrett K., Fujita T., Taniguchi T., Maini R., Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol. 1988 Feb;71(2):295–301. [PMC free article] [PubMed] [Google Scholar]
  10. Buchan G., Barrett K., Turner M., Chantry D., Maini R. N., Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol. 1988 Sep;73(3):449–455. [PMC free article] [PubMed] [Google Scholar]
  11. Campbell I. L., Cutri A., Wilkinson D., Boyd A. W., Harrison L. C. Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4282–4286. doi: 10.1073/pnas.86.11.4282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Campbell I. L., Cutri A., Wilson A., Harrison L. C. Evidence for IL-6 production by and effects on the pancreatic beta-cell. J Immunol. 1989 Aug 15;143(4):1188–1191. [PubMed] [Google Scholar]
  13. Campbell I. L., Iscaro A., Harrison L. C. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J Immunol. 1988 Oct 1;141(7):2325–2329. [PubMed] [Google Scholar]
  14. Campbell I. L., Kay T. W., Oxbrow L., Harrison L. C. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest. 1991 Feb;87(2):739–742. doi: 10.1172/JCI115055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Campbell I. L., Oxbrow L., Koulmanda M., Harrison L. C. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol. 1988 Feb 15;140(4):1111–1116. [PubMed] [Google Scholar]
  16. Campbell I. L., Oxbrow L., West J., Harrison L. C. Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha. Mol Endocrinol. 1988 Feb;2(2):101–107. doi: 10.1210/mend-2-2-101. [DOI] [PubMed] [Google Scholar]
  17. Cavallo M. G., Baroni M. G., Toto A., Gearing A. J., Forsey T., Andreani D., Thorpe R., Pozzilli P. Viral infection induces cytokine release by beta islet cells. Immunology. 1992 Apr;75(4):664–668. [PMC free article] [PubMed] [Google Scholar]
  18. Cavallo M. G., Pozzilli P., Bird C., Wadhwa M., Meager A., Visalli N., Gearing A. J., Andreani D., Thorpe R. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol. 1991 Nov;86(2):256–259. doi: 10.1111/j.1365-2249.1991.tb05806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Eizirik D. L., Tracey D. E., Bendtzen K., Sandler S. An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia. 1991 Jun;34(6):445–448. doi: 10.1007/BF00403185. [DOI] [PubMed] [Google Scholar]
  20. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 1984 Jan 19;307(5948):273–276. doi: 10.1038/307273a0. [DOI] [PubMed] [Google Scholar]
  21. Foulis A. K., Farquharson M. A., Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987 May;30(5):333–343. doi: 10.1007/BF00299027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Foulis A. K., Liddle C. N., Farquharson M. A., Richmond J. A., Weir R. S. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia. 1986 May;29(5):267–274. doi: 10.1007/BF00452061. [DOI] [PubMed] [Google Scholar]
  23. Gallo P., Piccinno M. G., Tavolato B., Sidén A. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. J Neurol Sci. 1991 Feb;101(2):227–232. doi: 10.1016/0022-510x(91)90050-h. [DOI] [PubMed] [Google Scholar]
  24. Gao E. K., Lo D., Cheney R., Kanagawa O., Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature. 1988 Nov 10;336(6195):176–179. doi: 10.1038/336176a0. [DOI] [PubMed] [Google Scholar]
  25. Goto M., Sasano M., Miyamoto T., Nishioka K., Nakamura K., Aotsuka S., Yokohari R. Lack of association of HLA-DR4 with interleukin 1 beta secretion from peripheral blood monocytes in patients with rheumatoid arthritis. J Rheumatol. 1989 Aug;16(8):1025–1028. [PubMed] [Google Scholar]
  26. Grubeck-Loebenstein B., Buchan G., Chantry D., Kassal H., Londei M., Pirich K., Barrett K., Turner M., Waldhausl W., Feldmann M. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6. Clin Exp Immunol. 1989 Sep;77(3):324–330. [PMC free article] [PubMed] [Google Scholar]
  27. Hamaguchi K., Leiter E. H. Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression. Diabetes. 1990 Apr;39(4):415–425. doi: 10.2337/diab.39.4.415. [DOI] [PubMed] [Google Scholar]
  28. Hammonds P., Beggs M., Beresford G., Espinal J., Clarke J., Mertz R. J. Insulin-secreting beta-cells possess specific receptors for interleukin-1 beta. FEBS Lett. 1990 Feb 12;261(1):97–100. doi: 10.1016/0014-5793(90)80645-y. [DOI] [PubMed] [Google Scholar]
  29. Hanafusa T., Fujino-Kurihara H., Miyazaki A., Yamada K., Nakajima H., Miyagawa J., Kono N., Tarui S. Expression of class II major histocompatibility complex antigens on pancreatic B cells in the NOD mouse. Diabetologia. 1987 Feb;30(2):104–108. doi: 10.1007/BF00274580. [DOI] [PubMed] [Google Scholar]
  30. Hanafusa T., Pujol-Borrell R., Chiovato L., Russell R. C., Doniach D., Bottazzo G. F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet. 1983 Nov 12;2(8359):1111–1115. doi: 10.1016/s0140-6736(83)90628-1. [DOI] [PubMed] [Google Scholar]
  31. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  32. Harrison L. C., Campbell I. L., Allison J., Miller J. F. MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms. Diabetes. 1989 Jul;38(7):815–818. doi: 10.2337/diab.38.7.815. [DOI] [PubMed] [Google Scholar]
  33. Heath W. R., Allison J., Hoffmann M. W., Schönrich G., Hämmerling G., Arnold B., Miller J. F. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature. 1992 Oct 8;359(6395):547–549. doi: 10.1038/359547a0. [DOI] [PubMed] [Google Scholar]
  34. Held W., MacDonald H. R., Weissman I. L., Hess M. W., Mueller C. Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2239–2243. doi: 10.1073/pnas.87.6.2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., Sato K., Shimizu M., Maini R., Feldmann M. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 1988 Nov;18(11):1797–1801. doi: 10.1002/eji.1830181122. [DOI] [PubMed] [Google Scholar]
  36. Hopkins S. J., Humphreys M., Jayson M. I. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol. 1988 Jun;72(3):422–427. [PMC free article] [PubMed] [Google Scholar]
  37. Huang Y. P., Miescher P. A., Zubler R. H. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol. 1986 Dec 1;137(11):3515–3520. [PubMed] [Google Scholar]
  38. Hughes J. H., Colca J. R., Easom R. A., Turk J., McDaniel M. L. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest. 1990 Sep;86(3):856–863. doi: 10.1172/JCI114785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jacob C. O., Aiso S., Michie S. A., McDevitt H. O., Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A. 1990 Feb;87(3):968–972. doi: 10.1073/pnas.87.3.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Jacob C. O., McDevitt H. O. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988 Jan 28;331(6154):356–358. doi: 10.1038/331356a0. [DOI] [PubMed] [Google Scholar]
  41. Jacob C. O., van der Meide P. H., McDevitt H. O. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med. 1987 Sep 1;166(3):798–803. doi: 10.1084/jem.166.3.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jiang Z., Woda B. A. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol. 1991 May 1;146(9):2990–2994. [PubMed] [Google Scholar]
  43. Kaye W. A., Adri M. N., Soeldner J. S., Rabinowe S. L., Kaldany A., Kahn C. R., Bistrian B., Srikanta S., Ganda O. P., Eisenbarth G. S. Acquired defect in interleukin-2 production in patients with type I diabetes mellitus. N Engl J Med. 1986 Oct 9;315(15):920–924. doi: 10.1056/NEJM198610093151502. [DOI] [PubMed] [Google Scholar]
  44. Kelley V. E., Gaulton G. N., Hattori M., Ikegami H., Eisenbarth G., Strom T. B. Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol. 1988 Jan 1;140(1):59–61. [PubMed] [Google Scholar]
  45. Kitas G. D., Salmon M., Farr M., Gaston J. S., Bacon P. A. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Clin Exp Immunol. 1988 Aug;73(2):242–249. [PMC free article] [PubMed] [Google Scholar]
  46. Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today. 1992 May;13(5):157–160. doi: 10.1016/0167-5699(92)90118-Q. [DOI] [PubMed] [Google Scholar]
  47. Kolb H., Zielasek J., Treichel U., Freytag G., Wrann M., Kiesel U. Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats. Eur J Immunol. 1986 Feb;16(2):209–212. doi: 10.1002/eji.1830160218. [DOI] [PubMed] [Google Scholar]
  48. Kroemer G., Wick G. The role of interleukin 2 in autoimmunity. Immunol Today. 1989 Jul;10(7):246–251. doi: 10.1016/0167-5699(89)90262-4. [DOI] [PubMed] [Google Scholar]
  49. Kuruvilla A. P., Shah R., Hochwald G. M., Liggitt H. D., Palladino M. A., Thorbecke G. J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918–2921. doi: 10.1073/pnas.88.7.2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Lang F., Pogu S., Maurel C., Charbonnel B., Sai P. Production of and response to interleukin 2 by blood mononuclear cells from some type 1 diabetic patients. Diabete Metab. 1987 Feb;13(1):37–43. [PubMed] [Google Scholar]
  51. Leiter E. H., Christianson G. J., Serreze D. V., Ting A. T., Worthen S. M. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. J Exp Med. 1989 Oct 1;170(4):1243–1262. doi: 10.1084/jem.170.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lo D., Burkly L. C., Widera G., Cowing C., Flavell R. A., Palmiter R. D., Brinster R. L. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell. 1988 Apr 8;53(1):159–168. doi: 10.1016/0092-8674(88)90497-7. [DOI] [PubMed] [Google Scholar]
  53. Londei M., Bottazzo G. F., Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science. 1985 Apr 5;228(4695):85–89. doi: 10.1126/science.3871967. [DOI] [PubMed] [Google Scholar]
  54. Londei M., Lamb J. R., Bottazzo G. F., Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature. 1984 Dec 13;312(5995):639–641. doi: 10.1038/312639a0. [DOI] [PubMed] [Google Scholar]
  55. Mandrup-Poulsen T., Bendtzen K., Dinarello C. A., Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol. 1987 Dec 15;139(12):4077–4082. [PubMed] [Google Scholar]
  56. Mandrup-Poulsen T., Bendtzen K., Nerup J., Egeberg J., Nielsen J. H. Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy. 1986 May;41(4):250–259. doi: 10.1111/j.1398-9995.1986.tb02025.x. [DOI] [PubMed] [Google Scholar]
  57. Mandrup-Poulsen T., Helqvist S., Mølvig J., Wogensen L. D., Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity. 1989;4(3):191–234. doi: 10.3109/08916938909003049. [DOI] [PubMed] [Google Scholar]
  58. Massa P. T., ter Meulen V., Fontana A. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4219–4223. doi: 10.1073/pnas.84.12.4219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Matsunaga M., Eguchi K., Fukuda T., Kurata A., Tezuka H., Shimomura C., Otsubo T., Ishikawa N., Ito K., Nagataki S. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. J Clin Endocrinol Metab. 1986 Apr;62(4):723–728. doi: 10.1210/jcem-62-4-723. [DOI] [PubMed] [Google Scholar]
  60. Merrill J. E., Strom S. R., Ellison G. W., Myers L. W. In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol. 1989 Mar;9(2):84–96. doi: 10.1007/BF00916935. [DOI] [PubMed] [Google Scholar]
  61. Miyasaka N., Nakamura T., Russell I. J., Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol. 1984 Apr;31(1):109–117. doi: 10.1016/0090-1229(84)90195-8. [DOI] [PubMed] [Google Scholar]
  62. Nicoletti F., Meroni P. L., Landolfo S., Gariglio M., Guzzardi S., Barcellini W., Lunetta M., Mughini L., Zanussi C. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma. Lancet. 1990 Aug 4;336(8710):319–319. doi: 10.1016/0140-6736(90)91860-d. [DOI] [PubMed] [Google Scholar]
  63. Palmer J. P., Helqvist S., Spinas G. A., Mølvig J., Mandrup-Poulsen T., Andersen H. U., Nerup J. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes. 1989 Oct;38(10):1211–1216. doi: 10.2337/diab.38.10.1211. [DOI] [PubMed] [Google Scholar]
  64. Piccinini L. A., Mackenzie W. A., Platzer M., Davies T. F. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers. J Clin Endocrinol Metab. 1987 Mar;64(3):543–548. doi: 10.1210/jcem-64-3-543. [DOI] [PubMed] [Google Scholar]
  65. Pujol-Borrell R., Todd I., Doshi M., Bottazzo G. F., Sutton R., Gray D., Adolf G. R., Feldmann M. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature. 1987 Mar 19;326(6110):304–306. doi: 10.1038/326304a0. [DOI] [PubMed] [Google Scholar]
  66. Pukel C., Baquerizo H., Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes. 1988 Jan;37(1):133–136. doi: 10.2337/diab.37.1.133. [DOI] [PubMed] [Google Scholar]
  67. Rabinovitch A., Sumoski W., Rajotte R. V., Warnock G. L. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab. 1990 Jul;71(1):152–156. doi: 10.1210/jcem-71-1-152. [DOI] [PubMed] [Google Scholar]
  68. Racke M. K., Dhib-Jalbut S., Cannella B., Albert P. S., Raine C. S., McFarlin D. E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol. 1991 May 1;146(9):3012–3017. [PubMed] [Google Scholar]
  69. Saklatvala J., Sarsfield S. J., Townsend Y. Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever. J Exp Med. 1985 Oct 1;162(4):1208–1222. doi: 10.1084/jem.162.4.1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Sarvetnick N., Liggitt D., Pitts S. L., Hansen S. E., Stewart T. A. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell. 1988 Mar 11;52(5):773–782. doi: 10.1016/0092-8674(88)90414-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Sarvetnick N., Shizuru J., Liggitt D., Martin L., McIntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature. 1990 Aug 30;346(6287):844–847. doi: 10.1038/346844a0. [DOI] [PubMed] [Google Scholar]
  72. Satoh J., Seino H., Abo T., Tanaka S., Shintani S., Ohta S., Tamura K., Sawai T., Nobunaga T., Oteki T. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest. 1989 Oct;84(4):1345–1348. doi: 10.1172/JCI114304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988 Apr;23(4):339–346. doi: 10.1002/ana.410230405. [DOI] [PubMed] [Google Scholar]
  74. Selmaj K., Nowak Z., Tchórzewski H. Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients. J Neurol Sci. 1988 May;85(1):67–76. doi: 10.1016/0022-510x(88)90036-6. [DOI] [PubMed] [Google Scholar]
  75. Selmaj K., Raine C. S., Cannella B., Brosnan C. F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest. 1991 Mar;87(3):949–954. doi: 10.1172/JCI115102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sharief M. K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med. 1991 Aug 15;325(7):467–472. doi: 10.1056/NEJM199108153250704. [DOI] [PubMed] [Google Scholar]
  77. Shintani S., Satoh J., Seino H., Goto Y., Toyota T. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction. J Immunol. 1990 Jan 1;144(1):136–141. [PubMed] [Google Scholar]
  78. Sumoski W., Baquerizo H., Rabinovitch A. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia. 1989 Nov;32(11):792–796. doi: 10.1007/BF00264909. [DOI] [PubMed] [Google Scholar]
  79. Svenson M., Kayser L., Hansen M. B., Rasmussen A. K., Bendtzen K. Interleukin-1 receptors on human thyroid cells and on the rat thyroid cell line FRTL-5. Cytokine. 1991 Mar;3(2):125–130. doi: 10.1016/1043-4666(91)90032-9. [DOI] [PubMed] [Google Scholar]
  80. Taverne J., Rayner D. C., Van der Meide P. H., Lydyard P. M., Bidey S. P., Cooke A. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma. Eur J Immunol. 1987 Dec;17(12):1855–1858. doi: 10.1002/eji.1830171229. [DOI] [PubMed] [Google Scholar]
  81. Todd I., Pujol-Borrell R., Hammond L. J., Bottazzo G. F., Feldmann M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol. 1985 Aug;61(2):265–273. [PMC free article] [PubMed] [Google Scholar]
  82. Varey A. M., Lydyard P. M., Dean B. M., Van der Meide P. H., Baird J. D., Cooke A. Interferon-gamma induces class II MHC antigens on RINm5F cells. Diabetes. 1988 Feb;37(2):209–212. doi: 10.2337/diab.37.2.209. [DOI] [PubMed] [Google Scholar]
  83. Vidovic M., Sparacio S. M., Elovitz M., Benveniste E. N. Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha. J Neuroimmunol. 1990 Dec;30(2-3):189–200. doi: 10.1016/0165-5728(90)90103-T. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Walker R., Cooke A., Bone A. J., Dean B. M., van der Meide P., Baird J. D. Induction of class II MHC antigens in vitro on pancreatic B cells isolated from BB/E rats. Diabetologia. 1986 Oct;29(10):749–751. doi: 10.1007/BF00870286. [DOI] [PubMed] [Google Scholar]
  85. Weetman A. P., Volkman D. J., Burman K. D., Gerrard T. L., Fauci A. S. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab. 1985 Nov;61(5):817–824. doi: 10.1210/jcem-61-5-817. [DOI] [PubMed] [Google Scholar]
  86. Whicher J. T., Gilbert A. M., Westacott C., Hutton C., Dieppe P. A. Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. Clin Exp Immunol. 1986 Jul;65(1):80–89. [PMC free article] [PubMed] [Google Scholar]
  87. Wilson C. A., Jacobs C., Baker P., Baskin D. G., Dower S., Lernmark A., Toivola B., Vertrees S., Wilson D. IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol. 1990 May 15;144(10):3784–3788. [PubMed] [Google Scholar]
  88. Wright J. R., Jr, Lacy P. E., Unanue E. R., Muszynski C., Hauptfeld V. Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells. Diabetes. 1986 Oct;35(10):1174–1177. doi: 10.2337/diab.35.10.1174. [DOI] [PubMed] [Google Scholar]
  89. Xu W. D., Firestein G. S., Taetle R., Kaushansky K., Zvaifler N. J. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest. 1989 Mar;83(3):876–882. doi: 10.1172/JCI113971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Zheng R. Q., Abney E. R., Chu C. Q., Field M., Maini R. N., Lamb J. R., Feldmann M. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells. Immunology. 1992 Mar;75(3):456–462. [PMC free article] [PubMed] [Google Scholar]
  91. Zheng R. Q., Abney E., Chu C. Q., Field M., Grubeck-Loebenstein B., Maini R. N., Feldmann M. Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin Exp Immunol. 1991 Feb;83(2):314–319. doi: 10.1111/j.1365-2249.1991.tb05634.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Zier K. S., Leo M. M., Spielman R. S., Baker L. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes. 1984 Jun;33(6):552–555. doi: 10.2337/diab.33.6.552. [DOI] [PubMed] [Google Scholar]
  93. di Giovine F. S., Poole S., Situnayake R. D., Wadhwa M., Duff G. W. Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int. 1990;9(6):259–264. doi: 10.1007/BF00541321. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES